Immunitybio Inc (IBRX)

EBITDA Margin

-440.99%

Quarterly · Period ending:

IBRX logo

IBRX EBITDA Margin

Latest reported-440.99%
IBRX Quarterly EBITDA Margin (-91859.34% → -440.99%)
High-resolution chart · PNG

IBRX ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Immunitybio Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
-440.9895%
-1,357.1619%
-81.0657%
-111.581%
-225.3207%
-588.5209%
-531.25%
-672.5516%
-8,706.6858%
-244,092.5%
-141,556.8345%
-68,395.122%
-247,063.4146%
-22,873.8889%
-102,097.2603%
-74,925.4237%
-225,005.7143%
-628,928.5714%
-21,401.7949%
-122,921.2121%
-24,136.2832%
-53,478.4173%
-140,480.9524%
-41,119.2053%
-10,630.9633%
-19,429.697%
-2,081.3043%
-111,450%
-88,811.7647%
-297,180%
-207,657.1429%
-67,219.3548%
-634,500%
-519,740%
-192,133.3333%
-277,675%
-157,485.7143%
-212,854.5455%
-160,792.8571%
-259,583.3333%
-280,933.3333%
-505,133.3333%
-547,985.7143%
-426,240%
-91,859.3407%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.